Latest Stories

WTO Wades Into Vaccine Feud as Merkel, Pharma Balk at Biden Plan

The pharmaceutical companies hate it. The Biden administration is embracing it. Now, finding common ground for wider distribution of Covid-19 vaccines in poorer countries falls to the World Trade Organization -- a body known more for its inability to do international deals than to clinch them.

Merck, Glenmark Argue to Undo Zetia Wholesalers’ Class Status

Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. argued Thursday that the Fourth Circuit should reverse a decision granting class status to wholesalers alleging the manufacturers entered into an anti-competitive agreement to delay entry of generic competition to the cholesterol drug Zetia.

U.S. Call to Waive Vaccine Patents Said to Snarl Immunity Effort

The success of an international waiver of patent protections on Covid-19 vaccines largely hangs on whether the U.S. forces its companies to share manufacturing specifications and may not be the harbinger of global immunization it’s cracked up to be, critics say.

View More

Coronavirus and Force Majeure Clauses

Covid-19 has legal teams exploring whether to turn to a rarely tested section of their contracts: the force majeure, or act of god, clause.

Up Next

Coronavirus Is Changing the Way Lawyers Work